T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,090.00
-30.00 (-0.59%)
Jun 17, 2025, 3:30 PM KST
-20.59%
Market Cap 109.67B
Revenue (ttm) 9.64B
Net Income (ttm) -5.32B
Shares Out 21.55M
EPS (ttm) -246.20
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 73,486
Average Volume 120,691
Open 5,120.00
Previous Close 5,120.00
Day's Range 4,960.00 - 5,120.00
52-Week Range 2,840.00 - 7,900.00
Beta 0.88
RSI 53.25
Earnings Date Aug 22, 2025

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Employees 93
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.